Enanta Pharmaceuticals, Inc. (ENTA) ownership: Top institutional holder: BlackRock Fund Advisors ($48.48M). Insider activity: Net Seller (4 buys, 16 sells). 1 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BlackRock Fund Advisors | 1447002.00 | $48.48M | 2016-12-31 |
| JANUS HENDERSON GROUP PLC | 3784055.00 | $47.72M | 2026-03-31 |
| BlackRock, Inc. | 3103768.00 | $39.20M | 2026-03-31 |
| VANGUARD GROUP INC | 2301794.00 | $36.30M | 2025-12-31 |
| FARALLON CAPITAL MANAGEMENT LLC | 2871862.00 | $36.27M | 2026-03-31 |
| Krensavage Asset Management, LLC | 2866138.00 | $36.20M | 2026-03-31 |
| Deep Track Capital, LP | 1956867.00 | $24.72M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1178049.00 | $14.88M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-03-11 | |
| Sell | null | 2026-03-11 | |
| Sell | null | 2026-03-11 | |
| Sell | null | 2026-03-11 | |
| Sell | null | 2026-03-11 | |
| Sell | null | 2026-03-11 | |
| Sell | null | 2026-02-12 | |
| Sell | null | 2026-02-12 |
Back to ENTA overview · ENTA earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.